)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Sanofi Consumer Healthcare India Limited
Sanofi Consumer Healthcare India Limited (SANOFICONR) investor relations material
Sanofi Consumer Healthcare India Limited Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2026 earnings summary28 Oct, 2026
Executive summary
Q3’26 revenue from operations was ₹2,631 million, up 12% YoY; PBT was ₹1,027 million, up 22% YoY.
Nine-month revenue was ₹7,280 million, up 16% YoY, and PBT increased 24% YoY.
Financial highlights
Q3’26 profit for the period was ₹766 million versus ₹629 million in Q3’25; nine-month profit was ₹2,132 million versus ₹1,736 million.
Q3’26 total income was ₹2,675 million versus ₹2,369 million YoY; nine-month total income was ₹7,443 million versus ₹6,412 million.
Product sales were ₹2,438 million in Q3’26 versus ₹2,132 million YoY; nine-month product sales were ₹6,634 million versus ₹5,715 million.
Segment performance
Operations are reported as one business segment, Pharmaceutical Business.
Domestic sales grew 19% in Q3’26 and 15% in 9M’26; nine-month domestic growth was aided by product relaunches.
Export sales grew 19% in 9M’26.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Sanofi Consumer Healthcare India Limited
- Q2 2026 revenue up 7% and net profit at ₹919 million, driven by domestic sales growth.SANOFICONR
Q2 2026 - Strong revenue and profit growth supported by robust domestic and export sales post-relaunch.SANOFICONRQ1 2026
- Double-digit growth achieved through brand leadership, digital focus, and operational excellence.SANOFICONRInvestor presentation
- FY25 net profit rose to ₹2,401 million on revenue of ₹8,045 million; ₹75/share dividend proposed.SANOFICONRQ4 2025
- Half-year net profit was ₹917 million, with results shaped by demerger and product recalls.SANOFICONRQ2 2024
- Q3 2024 revenue reached ₹1,599 million, with net profit at ₹450 million amid product recalls.SANOFICONRQ3 2024
- FY 2024 net profit reached ₹1,810 million, with strong core portfolio performance and a ₹55 dividend.SANOFICONRQ4 2024
- Q1 2025 net profit fell to ₹500 million amid product recalls; Depura Adult relaunched.SANOFICONRQ1 2025
- Q2 2025 revenue up 28% YoY and profit after tax up 21%, led by launches and export growth.SANOFICONRQ2 2025
Next Sanofi Consumer Healthcare India Limited earnings date
Q4 202619 Feb, 2027
Sanofi Consumer Healthcare India Limited
Next Sanofi Consumer Healthcare India Limited earnings date
Q4 202619 Feb, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)